Position in GERN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$911,518
+$1,637 QoQ
Shares Held
712,124
+16.6% QoQ
Ownership
0.111%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#51
of 258 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GERN Over Time
Shares Held
Position Value (USD)
Derivatives in GERN
reported options exposure · as of Dec 31, 2022CallValue
$0
CallShares
0
PutValue
$326,700
PutShares
135,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026J. Goldman & Co LP holds $154,729,761 across 52 Biotechnology names. GERN ranks #37 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | COGT |
Cogent Biosciences, Inc.
|
637,994 | $24,690,367 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
38,698 | $11,649,258 | |
| 3 | CAPR |
Capricor Therapeutics, Inc.
|
427,321 | $10,289,889 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
601,972 | $8,132,641 | |
| 5 | ARDX |
Ardelyx, Inc.
|
1,579,828 | $8,057,122 | |
| 6 | URGN |
UroGen Pharma Ltd.
|
212,775 | $7,830,120 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
12,311 | $6,115,243 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
112,129 | $5,690,546 |
All Filings in GERN
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $911,518 | 712,124 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $909,881 | 610,659 | Shares | Sole | 2026-05-15 | |
| 2025-06-30 | $121,821 | 86,398 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $137,372 | 86,398 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $5,910,681 | 1,669,684 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $800,125 | 176,239 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $171,720 | 40,500 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $862,610 | 261,397 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $326,700 | 135,000 | Put | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||